Healthtech startup Everlab Raises $45.9 Mn in Series A Round

The funding was led by Airtree Ventures from Australia. Other investors included Plural from Europe, existing investors Left Lane Capital and b2venture, as well as several angel investors, including Pat Cummins, captain of the Australian cricket team.

The new funding marks Everlab’s transformation into a complete healthcare platform focused on preventing illness rather than simply treating it after it occurs.

Today, many patients have to deal with disconnected healthcare services. Medical records are often stored separately by different providers, telehealth appointments usually offer little long-term follow-up, and wearable devices provide health data but often lack the clinical support needed to turn those insights into meaningful health outcomes. Everlab aims to bring these services together into one connected care experience.

“The existing system is fragmented, handing patients between providers and hoping the information follows,” says Marc Hermann, Co-founder and CEO of Everlab. “We built Everlab to hold the full picture, surface health blind spots and coordinate what needs to happen next—from targeted screenings to personalized health plans—helping more people live longer, healthier lives.”

“Our patient base reflects the broader Australian population, and earning their trust to hold decades of their health data is the foundation everything else runs on,” says Dr Steven Lu, the company’s Chief Medical Officer. “Our goal is to cut a new path for primary care globally, proving that deep patient engagement and first-class preventative care don’t just improve outcomes, it reduces the lifetime cost of care for everyone.”

“The more time we spent with the Everlab team, the more convinced we became that they’re building a generational health business. With a world-class product and growing at a pace we rarely see, they’re already the leader in Australia and we’re backing them to do the same globally,” says John Henderson, Partner at Airtree.

Carina Namih, Partner at Plural, added: “Every company that has tried to own the patient journey has ended up either selling doctor time by the minute or reselling lab tests with thin margins. Everlab is building the layer above both: the system that interprets and coordinates your health data over time rather than capturing a single transaction. The fact that they’ve already proven their model operationally in Australia, at scale, is what convinced me this is the version that genuinely works.”

Founded in 2023 by Steven Lu, Marc Hermann, and Anshul Jain, Everlab is a healthtech company that focuses on preventive and personalized healthcare. It uses data, artificial intelligence, advanced health testing and expert medical care to help people better understand their health.

By combining technology with clinician-led support, Everlab aims to identify potential health risks early and help prevent diseases before they become serious allowing people to take a more proactive approach to their health.

Read Also- Flyweel Raises $1.7 Mn in Pre-seed Round led by Ten13